Organogenesis
ORGO
$2.35
Share price
0.00%
Change (1 day)
14.63%
Change (1 year)
Categories
Operating Margin for Organogenesis (ORGO)
Operating Margin as of April 2024 (TTM): 4.70%
According to Organogenesis's latest financial reports and stock price the company's current Operating Margin is 4.70%. At the end of 2021 the company had an Operating Margin of 15.17%.
Operating Margin history for Organogenesis from 2019 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | 15.17% | 72.5% |
| 2020 | 8.80% | -173.33% |
| 2019 | -12.00% | -56.94% |
| 2018 | -27.86% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | -36.36% | -873.62% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | -8,391.15% | -178,635.11% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.